BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bellavite P. Causality assessment of adverse events following immunization: the problem of multifactorial pathology. F1000Res 2020;9:170. [PMID: 32269767 DOI: 10.12688/f1000research.22600.2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 De Marco G, Giryes S, Williams K, Alcorn N, Slade M, Fitton J, Nizam S, Smithson G, Iqbal K, Tran G, Pekarska K, Keen MUH, Solaiman M, Middleton E, Wood S, Buss R, Devine K, Marzo-Ortega H, Green M, McGonagle DG. A Large Cluster of New Onset Autoimmune Myositis in the Yorkshire Region Following SARS-CoV-2 Vaccination. Vaccines (Basel) 2022;10:1184. [PMID: 35893834 DOI: 10.3390/vaccines10081184] [Reference Citation Analysis]
2 Spinelli FR, Favalli EG, Garufi C, Cornalba M, Colafrancesco S, Conti F, Caporali R. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine. Arthritis Res Ther 2022;24:21. [PMID: 35016701 DOI: 10.1186/s13075-021-02674-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
3 Zhou Q, Zhou R, Yang H, Yang H. To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis. Front Immunol 2021;12:733418. [PMID: 34603311 DOI: 10.3389/fimmu.2021.733418] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
4 Pagar VS, Chavan SS, Patil SP, Borde A, Kinge AD, Khargekar N. Epidemiological study of adverse events following immunization in under 5 year children. J Family Med Prim Care 2021;10:2482-7. [PMID: 34568123 DOI: 10.4103/jfmpc.jfmpc_2328_20] [Reference Citation Analysis]
5 Sadaqat W, Habib S, Tauseef A, Akhtar S, Hayat M, Shujaat SA, Mahmood A. Determination of COVID-19 Vaccine Hesitancy Among University Students. Cureus 2021;13:e17283. [PMID: 34540503 DOI: 10.7759/cureus.17283] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Watad A, De Marco G, Mahajna H, Druyan A, Eltity M, Hijazi N, Haddad A, Elias M, Zisman D, Naffaa ME, Brodavka M, Cohen Y, Abu-Much A, Abu Elhija M, Bridgewood C, Langevitz P, McLorinan J, Bragazzi NL, Marzo-Ortega H, Lidar M, Calabrese C, Calabrese L, Vital E, Shoenfeld Y, Amital H, McGonagle D. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination. Vaccines (Basel) 2021;9:435. [PMID: 33946748 DOI: 10.3390/vaccines9050435] [Cited by in Crossref: 15] [Cited by in F6Publishing: 103] [Article Influence: 15.0] [Reference Citation Analysis]
7 Soy M, Keser G, Atagunduz P, Mutlu MY, Gunduz A, Koybaşi G, Bes C. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review. Clin Rheumatol 2021;40:3533-45. [PMID: 33751280 DOI: 10.1007/s10067-021-05700-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 10.0] [Reference Citation Analysis]
8 Soy M, Keser G, Atagunduz P, Mutlu MY, Gunduz A, Koybaşi G, Bes C. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review. Clin Rheumatol 2021;40:3533-45. [PMID: 33751280 DOI: 10.1007/s10067-021-05700-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
9 Bellavite P, Donzelli A. Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data. F1000Res 2020;9:1176. [PMID: 33335717 DOI: 10.12688/f1000research.26523.2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]